+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North American Deep Brain Stimulators Market 2019-2025

  • ID: 4969027
  • Report
  • January 2020
  • Region: North America, United States
  • Orion Market Research Private Limited

FEATURED COMPANIES

  • Boston Scientific Corp.
  • Cyberonics, Inc.
  • Medtronic Plc
  • Neuronetics Inc.
  • NeuroPace Inc.
  • Neurosigma
Deep brain stimulation is a method to implant electrodes in a certain area of the brain. The electrodes generate electrical impulse which regulates abnormal impulses. A device similar to the pacemaker is implanted under the skin of the upper chest. The wire travels under the skin and connects device to the electrode to the brain. Also, it is approved by the US FDA to reduce seizures in difficult-to-treat epilepsy, whose symptoms cannot be controlled by the use of medication. It is minimally invasive and involves creating small holes in the skull to implant the electrodes. By surgery, batteries under the skin in the chest are implanted.

Deep brain stimulation reversibly alters the abnormal function of the brain tissue in the region of the stimulating electrode. Patient with moderate disability from Parkinson's disease can opt for this surgery. Incidences of Parkinson's disease is increasing considerably across the globe. In 2017, as per the Institute for Health Metrics and Evaluation, incidence of Parkinson's disease was more than a million as compared to nearly 912,000 in 2013. Around 10 million people are living with Parkinson's disease in 2019, globally.

Some of the major companies working in the field of deep brain stimulation are Aleva Neurotherapeutics SA, Abbott Laboratories Incorporated, Boston Scientific Corporation, Cala Health, Incorporated, Functional Neuromodulation Limited, Livanova PLC, Medtronic PLC, Nevro Corporation, Nuvectra Corporation, Stimwave LLC and so on. The global market of deep brain stimulator is expected to reach $1.8 billion in 2025 as compared to $1.1 billion in 2018 with a CAGR of 7.2% during the forecast period.

In February 2019, Medtronic PLC launched deep brain stimulation for medically refractory epilepsy. The product was launched after pre-market approval from the US FDA for epilepsy as an adjunctive treatment for reducing the frequency of partial-onset seizures in individuals over 18 years of age. The US FDA approved it, based on the results from the SANTE (Stimulation of the anterior nucleus of the thalamus in epilepsy) trial.

Research Methodology

The market study of the North American Deep Brain Stimulators Market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. North American Deep Brain Stimulators Market Research and Analysis by Product
2. North American Deep Brain Stimulators Market Research and Analysis by Applications
3. North American Deep Brain Stimulators Market Research and Analysis by End-users

The Report Covers
  • Comprehensive research methodology of the North American Deep Brain Stimulators market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the North American Deep Brain Stimulators Market.
  • Insights about market determinants which are stimulating the North American Deep Brain Stimulators Market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Boston Scientific Corp.
  • Cyberonics, Inc.
  • Medtronic Plc
  • Neuronetics Inc.
  • NeuroPace Inc.
  • Neurosigma
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. North American Deep Brain Stimulators Market by Product
5.1.1. Single Channel
5.1.2. Dual Channel
5.2. North American Deep Brain Stimulators Market by Applications
5.2.1. Parkinson’s Disease
5.2.2. Depression
5.2.3. Others
5.3. North American Deep Brain Stimulators Market by End-Users
5.3.1. Hospitals and Clinics
5.3.2. Research Institutes

6. Regional Analysis
6.1. United States
6.2. Canada

7. Company Profiles
7.1. Abbott Laboratories (St. Jude Medical)
7.2. Boston Scientific Corp.
7.3. Cyberonics, Inc.
7.4. Functional Neuromodulation Ltd.
7.5. Medtronic Plc
7.6. Neuronetics Inc.
7.7. NeuroPace Inc.
7.8. Neurosigma
7.9. Neurosigma Inc.
7.10. Nevro Corp.
7.11. Synapse Biomedical, Inc.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories (St. Jude Medical)
  • Boston Scientific Corp.
  • Cyberonics, Inc.
  • Functional Neuromodulation Ltd.
  • Medtronic Plc
  • Neuronetics Inc.
  • NeuroPace Inc.
  • Neurosigma
  • Neurosigma Inc.
  • Nevro Corp.
  • Synapse Biomedical, Inc.
Note: Product cover images may vary from those shown